
Short-Rib Thoracic Dysplasia 13: Unraveling the Genetic Mysteries
Explore Short-rib Thoracic Dysplasia 13, its genetic causes, the role of DYNC2H1 mutations, and how genetic testing aids in diagnosis and personalized care.

MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.

Explore Short-rib Thoracic Dysplasia 13, its genetic causes, the role of DYNC2H1 mutations, and how genetic testing aids in diagnosis and personalized care.

Genetic testing for SRTD14 using whole-exome sequencing and validation assays aids in early diagnosis, empowering families with crucial information and support.

Explore how genetic testing aids in diagnosing short stature, microcephaly, and endocrine dysfunction. Learn the benefits of early diagnosis and personalized treatment.

Explore how genetic testing deciphers Short Stature with Nonspecific Skeletal Abnormalities, offering insights for diagnosis, personalized treatment, and family planning.

Explore the role of genetic testing in diagnosing and managing Silver-Russell Syndrome 3, understanding its genetic causes, and guiding personalized treatments.

Genetic testing reveals critical insights into Singleton-Merten Syndrome 2, aiding in early diagnosis, personalized treatment, and informed family planning decisions.

Unlock the potential of genetic testing to diagnose Spinocerebellar Ataxia Type 41 early, personalize treatments, and guide family planning for improved outcomes.

Uncover Spondylocostal Dysostosis 6's genetic roots. Explore genetic testing's role in carrier screening, early diagnosis, and advancements in SCD6-AR research.